Pterygium Clinical Trials

Find Pterygium Clinical Trials Near You

Cauterization Versus fibrin Glue for Conjunctival Autografting in Primary Pterygium Surgery

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Pterygium is a noncancerous growth of the conjunctival tissue over the cornea. It is a progressive disease that may lead to visual impairment in advanced stages, as well as restriction of ocular motility, chronic inflammation and cosmetic concerns. Surgical removal is the treatment of choice, but recurrence of pterygium is a frequent problem. In this randomized controlled cauterization will be compared with fibrin glue for conjunctival autografting in primary pterygium surgery.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• adults (older than 18 years of age)

• both sexes

• primary nasal pterygia ˃4 mm, which tends to increase, including patients with reduced visual acuity, chronic inflammation, cosmetic reasons

• if the patients had a bilateral pterygium, only one eye will be operated

Locations
Other Locations
Croatia
University Hospital Split
RECRUITING
Split
Time Frame
Start Date: 2018-05-08
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 164
Treatments
Experimental: Cauterization
Active_comparator: Fibrin glue
Related Therapeutic Areas
Sponsors
Collaborators: University Hospital of Split
Leads: University of Split, School of Medicine

This content was sourced from clinicaltrials.gov